AZD6738 was synergistic with antibody drug conjugate, MEDI2228, in MM cells similar to ATM inhibitor-MEDI2228 combinations (32), suggesting focused exposure to DNA damaging payloads may increase the dependence of MM on both DNA damaging pathways. This evidence concerns the gene ATM and Miyoshi myopathy.